- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06393062
Gram Stain of the First Urine After Puncture in Percutaneous Nephrolithotomy
January 20, 2025 updated by: Bedreddin Kalyenci, Adiyaman University
Gram Stain of the First Urine After Intraoperative Renal Puncture in Predicting the Systemic Inflammatory Response After Percutaneous Nephrolithotomy: A Prospective, Randomized Controlled Study
In this study, investigators compared the systemic inflammatory responses after percutaneous nephrolithotomy (PCNL) patients who were given an expanded empirical antibiotic regimen based on the prediction of the possibility of bacteria identified by Gram staining the first urine after renal puncture and patients whose antibiotic regimen was not performed and whose antibiotic regimen was adjusted according to patient symptoms and culture results.
Investigators aimed to test its diagnostic value in predicting and preventing complications.
Study Overview
Status
Recruiting
Conditions
Study Type
Interventional
Enrollment (Estimated)
245
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Bedreddin Kalyenci
- Phone Number: +905554859583
- Email: bedreddin84@windowslive.com
Study Locations
-
-
-
Adıyaman, Turkey, 02400
- Recruiting
- Adıyaman University, Medicine of Faculty
-
Contact:
- Bedreddin Kalyenci, MD
- Phone Number: +905554859583
- Email: bedreddin84@windowslive.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- patients with an indication for percutaneous nephrolithotomy due to kidney stone disease.
Exclusion Criteria:
- under 18 years old,
- having an active urinary tract infection before surgery and positive urine cultures,
- Patients with bilateral kidney stones,
- DJ stent or nephrostomy placement,
- Solitary kidney stones,
- Bleeding disorders,
- impaired kidney function,
- a history of antibiotic use for any reason within 2 weeks before randomization were excluded from the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Gram staining
Gram staining of post-puncture urine in percutaneous nephrolithotomy
|
Gram staining of the first urine after intraoperative renal puncture to predict the systemic inflammatory response after percutaneous nephrolithotomy.
|
|
No Intervention: control
non-intervention percutaneous nephrolithotomy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Efficacy of Gram stain in predicting systemic inflammatory response after percutaneous nephrolithotomy.
Time Frame: immediately after the surgery
|
Gram staining of urine after puncture to detect the presence of bacteria that are a possible source of infection according to the rate of gram-stained and non-gram-stained patients by microscopic examination.
|
immediately after the surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change of antibiotic regimen after bacterial estimation of Gram stain
Time Frame: immediately after the surgery
|
The percentage of patients whose antibiotic regimen was changed by estimating bacteria after Gram staining did not progress to systemic inflammatory response syndrome.
Systemic inflammatory response criteria: temperature less than 36 °C or higher than 38 °C, heart rate more than 100 beats per minute, respiratory rate more than 20 per minute, leukocyte count greater than 12 × 10 up 9/L or 4 × 10 up 9/L less than L, systolic blood pressure falling below 90 mmHg, or diastolic blood pressure falling below 40 mmHg
|
immediately after the surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 1, 2022
Primary Completion (Estimated)
August 31, 2025
Study Completion (Estimated)
September 30, 2025
Study Registration Dates
First Submitted
April 24, 2024
First Submitted That Met QC Criteria
April 26, 2024
First Posted (Actual)
May 1, 2024
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
January 20, 2025
Last Verified
January 1, 2025
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2022/7-17
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Patient clinical data before and after surgery
IPD Sharing Time Frame
starting 6 months after publication
IPD Sharing Access Criteria
Data will be shared with all researchers conducting research on the prevention and detection of infectious consequences after percutaneous nephrolithotomy.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Percutaneous Nephrolithotomy
-
Assiut UniversityNot yet recruitingPercutaneous Nephrolithotomy
-
Sohag UniversityNot yet recruitingPercutaneous Nephrolithotomy (PCNL)
-
Alexandria UniversityActive, not recruitingPercutaneous Nephrolithotomy (PCNL)Egypt
-
Ting HuangCompletedPercutaneous NephrolithotomyChina
-
Zealand University HospitalUnknown
-
Elazıg Fethi Sekin Sehir HastanesiCompletedRetrolaminar Block | Percutaneous Nephrolithotomy (PCNL)Turkey
-
Muharrem UcarUnknownAnalgesia | Percutaneous Nephrolithotomy
-
Ain Shams UniversityCompletedPercutaneous Nephrolithotomy (PCNL) | Renal Stone DiseaseEgypt
-
Elazıg Fethi Sekin Sehir HastanesiRecruitingSystemic Inflammation | Percutaneous Nephrolithotomy | Anesthesia TechniquesTurkey (Türkiye)